Sort
39,280 grants matching “leukemia”
Specimen Acquistition and Expression Profiling
$415,071Mark A Watson · Washington University · P01 · FY2011 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$415,058University Of Arizona · U10 · FY2000 · CA
Transcriptional Networks Controlling Erythroid Differentiation
$415,049Gerd A Blobel · Children'S Hosp Of Philadelphia · R01 · FY2009 · DK
Safe, Silencing-Resistant, Non-Oncogenic Globin Expression Cassettes
$415,000Eric E Bouhassira · Albert Einstein College Of Medicine · R01 · FY2010 · HL
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
$415,000Hannah Choe · Ohio State University · R01 · FY2022 · CA
Safe, Silencing-Resistant, Non-Oncogenic Globin Expression Cassettes
$415,000Eric E Bouhassira · Albert Einstein College Of Medicine · R01 · FY2007 · HL
Regulation of Embryonic Erythropoiesis by BMP Signaling
$415,000Todd R Evans · Albert Einstein College Of Medicine · R01 · FY2007 · HL
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
$415,000Hannah Choe · Ohio State University · R01 · FY2025 · CA
Transfusion of Donor Effector Memory T Cells for GVL and Immune Reconstitution
$415,000Mark J Shlomchik · Yale University · R01 · FY2012 · HL
Role of Tissue Antigen Presenting Cells in GVHD
$415,000Warren D Shlomchik · Yale University · R01 · FY2012 · HL
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
$415,000Hannah Choe · Ohio State University · R01 · FY2021 · CA
Regulation of Embryonic Erythropoiesis by BMP Signaling
$415,000Todd R Evans · Albert Einstein College Of Medicine · R01 · FY2008 · HL
DC-ASGPR as Novel Target for Controlling GVHD and Allograft Rejection
$415,000Sangkon Oh · Mayo Clinic Arizona · R01 · FY2018 · AI
Analysis of Glutamatergic Neurons Derived from Patient-Specific iPS Cells
$415,000Herbert M Lachman · Albert Einstein College Of Medicine · R33 · FY2010 · MH
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars
$415,000Charles J Dimitroff · Brigham And Women'S Hospital · R01 · FY2009 · AT
Tumor maintenance and development in mouse models
$415,000Sloan-Kettering Institute For Cancer Res · U01 · FY2004 · CA
Mechanisms of arsenical transport
$414,950Barry P. Rosen · Wayne State University · R37 · FY2007 · GM
Biochemistry of Leukemia Virus Core Binding Factor
$414,931Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2015 · HL
Antiviral Mechanism of IFITM Proteins during HIV and Other Retrovirus Infections
$414,926Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Genetic Basis of Myeloid Neoplasia--Mutagenesis Screens
$414,833Dana-Farber Cancer Institute · R01 · FY2001 · CA
Biochemistry and Regulation of V(D)J Recombination
$414,829Mark S. Schlissel · University Of California Berkeley · R37 · FY2011 · AI
Characterizing MSI2 in leukemia
$414,827Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Characterizing MSI2 in leukemia
$414,827Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Characterizing MSI2 in leukemia
$414,827Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Characterizing MSI2 in leukemia
$414,827Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA